United Therapeutics (UTHR) - Dividend History and Outstanding Shares

Currently (October 2024) UTHR does not pay dividends. Last Dividend paid: .

No Dividends
As of October 2024, United Therapeutics (UTHR) does not pay a dividend.

Outstanding Shares

What is the Trend of UTHR`s Outstanding Shares?

The Outstanding Shares of United Therapeutics are shrinking at a rate of -0.77% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is -19.57%. Investors should be aware that the price of a stock often is positively affected by a decreasing number of shares.

Did United Therapeutics ever had a Stock Split?

Yes, last Stock Split was on 2009-09-23 with a factor of 2:1. This stock split increased the number of shares and lowered the price per share by a ratio of 2.

Year Number of Shares (Mill.) Growth
2023 50 +2.04%
2022 49 +4.26%
2021 47 +4.44%
2020 45 +2.27%
2019 44
2018 44 -2.22%
2017 45 -4.26%
2016 47 -7.84%
2015 51 -5.56%
2014 54 +1.89%
2013 53
2012 53 -10.17%
2011 59 -1.67%
2010 60 +7.14%
2009 56

Dividend Yields, Growth & Consistency

Overall Dividend Rating -
Dividends Paid 12m - Yield 12m -
Payout Consistency - Yield on Cost 5y -
Growth Rate 5y - Correlation Rate 5y -
First Payout - Next Payout -
Compare UTHR Dividends with its Industry Peers

No Dividends Paid

-

  • UTHR`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price 370.26.
  • 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by the price 5 years ago).
  • The 0.0% Payout Consistency of UTHR Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
  • The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases UTHR`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to 100.
Ratings surpassing 50 are regarded as favorable, while those exceeding 75 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.